Relx PLC · LSE:REL

Relx — FY2016 Earnings Presentation

31 slides from Relx's earnings presentation, February 2017

  1. Slide 1: RELX Group Results 2016

    RELX Group Results 2016 Erik Engstrom, CEO Nick Luff, CFO 2 1

  2. Slide 2: Forward-Looking Statements

    FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements within the meaning of Section 27A of the US Securities Act of 1933, as amended, and Section 21E of the US Securities Exchange Act of 1934, as amended. These statements are subject to a number of risks and uncertainties

  3. Slide 3: Erik Engstrom, CEO

    Erik Engstrom, CEO G.RELX Group G.RELX Group

  4. Slide 4: RELX Group 2016 progress; 2016 financial highlights

    RELX Group 2016 progress • Positive financial performance – Slight increase in underlying revenue growth rate – Underlying revenue and operating profit growth across all four business areas • Further strategic and operational progress – Continued improvement in business profile – Organic development

  5. Slide 5: Financial performance; underlying revenue and adjusted operating profit

    Financial performance Underlying revenue growth* Underlying adjusted operating profit growth +6% +6% +5% +5% +5% +4% +3% +3% +3% +3% 2012 2013 2014 2015 2016 2012 2013 2014 2015 2016 * excluding exhibition cycling effects Adjusted earnings per share growth Return on invested capital Constant currenc

  6. Slide 6: Scientific, Technical & Medical; Risk & Business Analytics

    Scientific, Technical & Medical Underlying growth Revenue • Key business trends remained positive • In primary research strong growth in usage and article submissions continued; 64 new journals launched +2% +2% • Good growth in databases & tools, and in electronic reference products 2015 2016 • Prin

  7. Slide 7: Legal; Exhibitions

    Legal Underlying growth Revenue • Underlying revenue growth improved slightly • Continued growth in electronic revenues partially offset by print declines +1% +2% • US and European markets stable but subdued; revenue from other international markets grew well 2015 2016 Adjusted operating profit • Ro

  8. Slide 8: RELX Group strategic direction: unchanged; Organic development

    RELX Group strategic direction: unchanged Where we are going • Deliver improved outcomes to professional customers • Combine content & data with analytics & technology in global platforms • Build leading positions in long term global growth markets • Leverage institutional skills, assets and resourc

  9. Slide 9: Portfolio reshaping

    Portfolio reshaping 2016: Strategy consistent Selective acquisitions: Focused on data sets, analytics and high growth markets • 17 acquisitions completed; total consideration £338m • Including Indicium Financial, Appriss Police Records, FlightStats, Diio, Intelligize Selective disposals of non strat

  10. Slide 10: Nick Luff, CFO; 2016 financial highlights

    Nick Luff, CFO 19 2016 financial highlights Income statement highlights • Improved underlying revenue growth +4% • Underlying adjusted operating profit growth ahead of revenue growth +6% • Adjusted operating profit margin 20 basis points higher 30.7% • Adjusted EPS growth at constant currencies +8%

  11. Slide 11: Income statement; Earnings per share

    Income statement change 2015 2016 constant change Year to 31 December £m £m change currency underlying Revenue 5,971 6,895 +15% +4% +4% Adjusted operating profit 1,822 2,114 +16% +4% +6% Adjusted operating margin 30.5% 30.7% Adjusted net interest expense (153) (180) Adjusted profit before tax 1,669

  12. Slide 12: Dividends per share; Revenue

    Dividends per share Exchange PLC rate NV Interim dividend 2016 10.25p x€1.19 €0.122 Growth +39% +6% Final dividend 2016 25.70p x€1.17 €0.301 Growth +15% +5% Total dividend 2016 35.95p €0.423 Growth +21% +5% Dividend cover 2.0x 2.1x • Dividend policy unchanged. Continue to grow dividends broadly in l

  13. Slide 13: Adjusted operating profit; Adjusted operating margin

    Adjusted operating profit Underlying growth in all business areas change 2015 2016 constant change Year to 31 December £m £m change currency underlying Scientific, Technical & Medical 760 853 +12% +2% +3% Risk & Business Analytics 575 686 +19% +8% +9% Legal 274 311 +14% +2% +12% Exhibitions 217 269

  14. Slide 14: Currency profile; Balance sheet

    Currency profile Revenue by geographic market 2016 • Revenue by currency broadly matches geographic split Rest of World 20% • Hedging smoothes volatility in sterling and euro reported results North Rest of America Europe 55% • At current exchange rates positive 18% impact on 2017 adjusted EPS growth

  15. Slide 15: Return on invested capital; Free cash flow

    Return on invested capital 2015 2016 Year to 31 December £m £m Adjusted operating profit 1,822 2,114 Tax at effective rate (424) (480) Effective tax rate 23.2% 22.7% Adjusted operating profit after tax 1,398 1,634 Average invested capital 10,995 12,538 Return on invested capital 12.7% 13.0% 29 Free

  16. Slide 16: Uses of free cash flow; Uses of cash - priorities

    Uses of free cash flow 2015 2016 Year to 31 December £m £m Free cash flow 1,186 1,414 Disposals: total consideration 73 16 Acquisitions: total consideration (171) (338) Dividends (583) (683) Share buybacks (500) (700) Other* (118) (118) Currency translation (119) (509) Movement in net debt (232) (91

  17. Slide 17: Erik Engstrom, CEO: Summary

    Erik Engstrom, CEO 33 Summary 2016 • Continued positive financial performance • Further strategic and operational progress 2017 Outlook “Key business trends in the early part of 2017 are consistent with the early part of 2016, and we are confident that, by continuing to execute on our strategy, we w

  18. Slide 18: This slide is intentionally left blank

    This slide is intentionally left blank 35 This slide is intentionally left blank 36 18

  19. Slide 19: Appendices Contents

    Appendices 37 Contents Further information Financial information in euros 40 Reconciliation of operating profit 53 Income statement 41 STM growth and currency analysis 54 Revenue by business area 42 Exhibitions: cycling impact 55 Adjusted operating profit by business area 43 STM revenue analysis 56

  20. Slide 20: Reconciliation of operating profit

    Further information 39 Reconciliation of operating profit Adjusted to reported 2015 2016 Year to 31 December £m £m change Adjusted operating profit 1,822 2,114 +16% Adjustments: Amortisation of acquired intangible assets (296) (346) Acquisition related costs (35) (51) Reclassification of tax in join

  21. Slide 21: STM growth and currency analysis; Exhibitions cycling impact

    Scientific, Technical & Medical Growth and currency analysis £ Period Acquisitions/ Constant change in Other Total Underlying disposals currency hedge rates currency currency Total 2016 Revenue +2% 0% +2% -1% +11% +10% +12% Adjusted operating profit +3% -1% +2% -1% +11% +10% +12% Adjusted operating

  22. Slide 22: STM and Risk & Business Analytics revenue analysis

    Scientific, Technical & Medical 2016 revenue £2,320m Format Geography Type Advertising Print* 3% Rest of World North Transactional 20% 32% America 27% 42% Face-to-face 1% Electronic Europe Subscription 79% 26% 70% * Print book revenue 10% 43 Risk & Business Analytics 2016 revenue £1,906m Format Geog

  23. Slide 23: Legal and Exhibitions revenue analysis

    Legal 2016 revenue £1,622m Format Geography Type Print Rest of World 12% Transactional 18% 20% Face-to-face 0% Europe 20% Electronic Subscription North America 82% 80% 68% 45 Exhibitions 2016 revenue £1,047m Format Geography Type Electronic 3% Rest of World North America 37% 20% Face-to-face Europe

  24. Slide 24: Debt profile; Exchange rates and shares outstanding

    Debt profile Debt as at 31 December 2016: Gross debt: $6.0bn (£4.8bn); Net debt: $5.8bn (£4.7bn) Maturity Currency <1 Other year US >5 Euro Dollar years 1-3 3-5 years Sterling years • FY 2016 interest rate on gross debt of 3.8% (FY 2015: 3.8%) 47 Exchange rates and shares outstanding At 31 Dec At 31

  25. Slide 25: Capital expenditure and depreciation by business area

    Capital expenditure by business area 2015 2016 % of % of Year to 31 December £m revenues £m revenues Scientific, Technical & Medical 74 4% 85 4% Risk & Business Analytics 56 4% 67 4% Legal 150 10% 155 10% Exhibitions 27 3% 26 3% Total capital expenditure 307 5.1% 333 4.8% 49 Depreciation by business

  26. Slide 26: Term debt maturities; Financial information in euros

    Term debt maturities At 31 December 2016 $m 1,000 800 600 993 871 819 400 774 791 580 200 282 150 200 - 0 0 7 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 >2027 Term debt translated at 31 December 2016 exchange rates, stated at par value 51 Financial information in euros 52 26

  27. Slide 27: Income statement; Revenue (euros)

    Income statement change 2015 2016 constant change Year to 31 December €m €m change currency underlying Revenue 8,240 8,412 +2% +4% +4% Adjusted operating profit 2,514 2,579 +3% +4% +6% Adjusted operating margin 30.5% 30.7% Adjusted net interest expense (211) (220) Adjusted profit before tax 2,303 2,

  28. Slide 28: Adjusted operating profit; Free cash flow (euros)

    Adjusted operating profit Underlying growth in all business areas change 2015 2016 constant change Year to 31 December €m €m change currency underlying Scientific, Technical & Medical 1,049 1,041 -1% +2% +3% Risk & Business Analytics 794 837 +5% +8% +9% Legal 378 379 0% +2% +12% Exhibitions 299 328

  29. Slide 29: Uses of free cash flow; Reconciliation of operating profit (euros)

    Uses of free cash flow 2015 2016 Year to 31 December €m €m Free cash flow 1,638 1,726 Disposals: total consideration 101 20 Acquisitions: total consideration (236) (412) Dividends (805) (833) Share buybacks (690) (854) Other* (164) (143) Currency translation (409) 141 Movement in net debt (565) (355

  30. Slide 30: STM growth and currency analysis; Balance sheet (euros)

    Scientific, Technical & Medical Growth and currency analysis € Period Acquisitions/ Constant change in Other Total Underlying disposals currency hedge rates currency currency Total FY 2016 Revenue +2% +0% +2% -1% -2% -3% -1% Adjusted operating profit +3% -1% +2% -1% -2% -3% -1% Adjusted operating ma

  31. Slide 31: Capital expenditure and depreciation by business area (euros)

    Capital expenditure by business area 2015 2016 % of % of Year to 31 December €m revenues €m revenues Scientific, Technical & Medical 102 4% 103 4% Risk & Business Analytics 78 4% 82 4% Legal 206 10% 189 10% Exhibitions 38 3% 32 3% Total capital expenditure 424 5.1% 406 4.8% 61 Depreciation by busine

RELX — FY2016 Earnings Presentation on 6ix